RxDoctor Payments Data

Estrella Vega, MD

Family Medicine · Apopka, FLNPI 1598971020

Payments from drug & device makers

$250in general payments, 2019–2025

Across 12 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$62
  • GSK$39
  • Bayer$31
  • Dexcom, Inc.$28
  • Lilly USA, LLC$21
  • Pfizer$21
  • plus $47 from 3 others

What the payments were for

  • Food & beverage$250100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$250 in reported general payments places this provider in the 35th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$86,071
Medicare patients
224
Services billed
730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$25,202
OzempicSemaglutide17$20,828
XareltoRivaroxaban26$16,764
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$14,400
JanuviaSitagliptin Phosphate16$12,087
OxycontinOxycodone Hcl18$8,675
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$7,996
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,992
SynthroidLevothyroxine Sodium30$2,610
Novolog FlexpenInsulin Aspart13$2,407
Levothyroxine Sodium230$2,334
Atorvastatin Calcium158$1,558
Rosuvastatin Calcium80$1,438
Fenofibrate27$1,162
Carbidopa-LevodopaCarbidopa/Levodopa12$1,146

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$25,20227 claims
GSKTrelegy Ellipta$39$14,40016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Apopka

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →